VANCOMYCIN (INTRAOCULAR) OPHTHALMIC, P.F. (BSS) 0.4% (4MG/ML) (0.4MG/0.1ML) INJE 400 ML; VANCOMYCIN (INTRAOCULAR) OPHTHALMIC, P.F. 1MG/0.1ML (10MG/ML) INJECTABLE 0.1 ML 0.2 ML 1 ML 100 ML 150 ML 2 ML 2 MLS 5 ML 50 ML 6 ML 95 ML; VANCOMYCIN HCL, FTV** 1GM INJECTABLE 3 VIAL 4 VIAL; VANCOMYCIN, FORTIFIED 1% (10MG/ML) OPHTHALMIC 10 ML; VANCOMYCIN, FORTIFIED 1.5% (15MG/ML) OPHTHALMIC 15 ML; VANCOMYCIN, FORTIFIED 2% (20MG/ML) OPHTHALMIC 10 ML 15 ML; VANCOMYCIN, FORTIFIED 2.5% (25MG/ML) OPHTHALMIC 10 ML 15 ML; VANCOMYCIN, FORTIFIED 5% (50MG/ML) OPHTHALMIC 10 ML 15 ML 5 ML; VANCOMYCIN, LYOPHILIZED, OPHTHALMIC KIT 1% KIT 1 KIT 1 VIAL 14 KIT 2 KIT 2 KITS 20 KIT 3 KIT 3 KITS 4 KIT 4 KITS 4 VIALS 5 KIT 6 KIT 6 VIAL 9 KIT; VANCOMYCIN, SDPF - (0.2ML SYRINGE, 30G, 1/2") 1% INJECTABLE 0.4 ML 0.6 ML 0.8 ML 1 ML 1.2 ML 1.6 ML (44 DIFFERENT PRODUCTS)
Publicado el 22 de agosto de 2012 · Inicio del retiro: 21 de mayo de 2012
Resumen
FDA registra el retiro D-1638-2012 de medicamentos de Clase II, publicado el 22 de agosto de 2012 e iniciado el 21 de mayo de 2012. Empresa responsable: Franck's Lab Inc., d.b.a. Franck's Compounding Lab; Estado: Finalizado; Cantidad reportada: 224 units; Lote: Rx #'s: 0389516 0354047 0389060 0389207 0405939 0402042 0400827 0398001 0398001 0400827 0403914 0369558 0398001 0398001 0382651 0398001 0401260 0401260 0388232 0391059 0392294 0405026 0383386 0396250 0398226 0400971 0409026 0388709 0388791 0393212 0393212 0388791 0392126 0354819 0355230 0363386 0363473 0364197 0368230 0368499 0368573 0368881 0375045 0379341 0379553 0383464 0387849 0389351 0389391 0390955 0392188 0394445 0394681 0394937 0395427 0395954 0396732 0397082 0404021 0404798 0405706 0406017 0408990 0409845 0365234 0393460 0359175 0348859 0351904 0356879 0363386 0364197 0364237 0365742 0366033 0366278 0374625 0375045 0376068 0376172 0380555 0383380 0384293 0387373 0387484 0388897 0392019 0392074 0392237 0394445 0395775 0395954 0397082 0399965 0399990 0403522 0404021 0405332 0407337 0384730 0387512 0389305 0396300 0353129 0355934 0362691 0363386 0363664 0364588 0368573 0368881 0371798 0375690 0376829 0380347 0383380 0387484 0388897 0392019 0392331 0392542 0392778 0394517 0395954 0395388 0355439 0358613 0362691 0366278 0375410 0375512 0375513 0375516 0375517 0375520 0375690 0384293 0387482 0392331 0408623 0376092 0399725 0354424 0392778 0405107 0408480 0408826 0373371 0375355 0375502 0375505 0375508 0375509 0375512 0375513 0375516 0375517 0375520 0392019 0392331 0395775 0398876 0368828 0392019 0358047 0387426 0391713 0393523 0404318 0391713 0391703 0402014 0391703. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Franck's Lab Inc., d.b.a. Franck's Compounding Lab
- Distribuidor
- Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies
- Lote
- Rx #'s: 0389516 0354047 0389060 0389207 0405939 0402042 0400827 0398001 0398001 0400827 0403914 0369558 0398001 0398001 0382651 0398001 0401260 0401260 0388232 0391059 0392294 0405026 0383386 0396250 0398226 0400971 0409026 0388709 0388791 0393212 0393212 0388791 0392126 0354819 0355230 0363386 0363473 0364197 0368230 0368499 0368573 0368881 0375045 0379341 0379553 0383464 0387849 0389351 0389391 0390955 0392188 0394445 0394681 0394937 0395427 0395954 0396732 0397082 0404021 0404798 0405706 0406017 0408990 0409845 0365234 0393460 0359175 0348859 0351904 0356879 0363386 0364197 0364237 0365742 0366033 0366278 0374625 0375045 0376068 0376172 0380555 0383380 0384293 0387373 0387484 0388897 0392019 0392074 0392237 0394445 0395775 0395954 0397082 0399965 0399990 0403522 0404021 0405332 0407337 0384730 0387512 0389305 0396300 0353129 0355934 0362691 0363386 0363664 0364588 0368573 0368881 0371798 0375690 0376829 0380347 0383380 0387484 0388897 0392019 0392331 0392542 0392778 0394517 0395954 0395388 0355439 0358613 0362691 0366278 0375410 0375512 0375513 0375516 0375517 0375520 0375690 0384293 0387482 0392331 0408623 0376092 0399725 0354424 0392778 0405107 0408480 0408826 0373371 0375355 0375502 0375505 0375508 0375509 0375512 0375513 0375516 0375517 0375520 0392019 0392331 0395775 0398876 0368828 0392019 0358047 0387426 0391713 0393523 0404318 0391713 0391703 0402014 0391703
- Clasificación de riesgo
- Class II
- Área (FDA)
- drug
- País
- United States
Retiros relacionados
- FDADICLOFENAC SODIUM, SDPF - (0.1ML SYRINGE, 30G, 1/2") 500MCG/0.1ML INJECTABLE 0.5 ML, 2 ML, 4 ML (3 DIFFERENT22 de agosto de 2012
- FDACOPPER GLUCONATE 2MG/ML INJECTABLE 30 ML, 60 ML (2 DIFFERENT PRODUCTS)22 de agosto de 2012
- FDAMITOMYCIN/LIDOCAINE/EPINEPHRINE 0.04%/0.02%/0.1% INJECTABLE 5 ML; MITOMYCIN/LIDOCAINE/EPINEPHRINE22 de agosto de 2012
- FDAVANCOMYCIN/DEXAMETHASONE, LYOPHILIZED 1%/0.1% KIT 2 KIT 20 KIT 24 KIT (3 DIFFERENT PRODUCTS)22 de agosto de 2012
- FDAVANADYL SULFATE SOLUTION 200MCG/ML INJECTABLE 60 ML (1 PRODUCT)22 de agosto de 2012
- FDAULTRA-TEST 200 (CYP 80%/PROP 20%) 200MG/ML INJECTABLE 1 ML 10 ML 10 MLS 12 ML 15 ML 18 ML 2 ML 20 ML 20 MLS 2422 de agosto de 2012
Preguntas sobre este retiro
¿VANCOMYCIN (INTRAOCULAR) OPHTHALMIC, P.F. (BSS) 0.4% (4MG/ML) (0.4MG/0.1ML) INJE 400 ML; VANCOMYCIN (INTRAOCULAR) OPHTHALMIC, P.F. 1MG/0.1ML (10MG/ML) INJECTABLE 0.1 ML 0.2 ML 1 ML 100 ML 150 ML 2 ML 2 MLS 5 ML 50 ML 6 ML 95 ML; VANCOMYCIN HCL, FTV** 1GM INJECTABLE 3 VIAL 4 VIAL; VANCOMYCIN, FORTIFIED 1% (10MG/ML) OPHTHALMIC 10 ML; VANCOMYCIN, FORTIFIED 1.5% (15MG/ML) OPHTHALMIC 15 ML; VANCOMYCIN, FORTIFIED 2% (20MG/ML) OPHTHALMIC 10 ML 15 ML; VANCOMYCIN, FORTIFIED 2.5% (25MG/ML) OPHTHALMIC 10 ML 15 ML; VANCOMYCIN, FORTIFIED 5% (50MG/ML) OPHTHALMIC 10 ML 15 ML 5 ML; VANCOMYCIN, LYOPHILIZED, OPHTHALMIC KIT 1% KIT 1 KIT 1 VIAL 14 KIT 2 KIT 2 KITS 20 KIT 3 KIT 3 KITS 4 KIT 4 KITS 4 VIALS 5 KIT 6 KIT 6 VIAL 9 KIT; VANCOMYCIN, SDPF - (0.2ML SYRINGE, 30G, 1/2") 1% INJECTABLE 0.4 ML 0.6 ML 0.8 ML 1 ML 1.2 ML 1.6 ML (44 DIFFERENT PRODUCTS) fue retirado del mercado?
Sí. FDA publicó el retiro D-1638-2012 el 22 de agosto de 2012. Peligro reportado: Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter